Utility of frozen-section analysis of sentinel lymph node biopsy specimens for melanoma in surgical decision making

American Journal of Surgery

Volumn 196, Issue 6, 2008, Pages 827-833

  Alkhatib, Weesam ^a   Hertzenberg, Casey ^a   Jewell, William ^a   Al Kasspooles, Mazin F ^a   Damjanov, Ivan ^a   Cohen, Mark S ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Completion nodal dissection; Frozen section; Melanoma; Sentinel lymph nodes

Indexed keywords

ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC ACCURACY; EXCISION; FEMALE; FROZEN SECTION; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

DECISION MAKING; DIAGNOSIS, DIFFERENTIAL; FEMALE; FROZEN SECTIONS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 57449103541     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.07.034     Document Type: Article

References (25)

1. Cancer Facts and Figures: Report on Leading Sites of New Cancer Cases and Deaths-2008 Estimates. American Cancer Society (2008). www.cancer.org
2. Thompson J.F., Morton D.L., and Kroon B.B.R. Textbook of Melanoma (2004), Martin Dunitz, London 7-8
3. Essner R. Experimental frontiers for clinical applications: novel approaches to understanding mechanisms of lymph node metastases in melanoma. Cancer Metastasis Rev 25 (2006) 257-267
4. Nathanson S.D. Insights into the mechanisms of lymph node metastasis. Cancer 98 (2003) 413-423
5. The Melanoma Research Foundation. Melanoma Fact Sheet Vol. 2007 (2007), The Melanoma Research Foundation, Hillsborough, NJ
6. Hochwald S.N., and Coit D.G. Role of elective lymph node dissection in melanoma. Semin Surg Oncol 14 (1998) 276-282
7. Wagner J.D., Gordon M.S., Chuang T.Y., et al. Current therapy of cutaneous melanoma. Plast Reconstr Surg 105 (2000) 1774-1800
8. Fischer B., and Fischer E.R. Studies concerning the regional lymph node. II. Maintenance of immunity. Cancer 27 (1971) 1001-1004
9. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
10. Cascinelli N., Belli F., Santinami M., et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol (2000) 469-474
11. National Cancer Comprehensive Network Practice Guidelines for Oncology. Melanoma Version 1 (2009) 1-40. www.nccn.org
12. Vuylsteke R.J., Van Leeuwen P.A., Statius Muller M.G., et al. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol 21 (2003) 1057-1065
13. Koopal S.A., Tiebosch A., Piers A., et al. Frozen section analysis of sentinel lymph modes in melanoma patients. Cancer 89 (2000) 1720-1725
14. Ariyan S., Ariyan C., Farber L.R., et al. Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma. J Am Coll Surg 198 (2004) 924-932
15. Tanis P.J., Boom P., Schraffordt Koops H., et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 8 (2001) 222-226
16. Scolyer R.A., Thompson J.F., McCarthy S.W., et al. Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. J Am Coll Surg 201 (2005) 821-823
17. Nowecki Z.I., Rutkowski P., Nasierowska-Guttmejer A., et al. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol 13 (2006) 1655-1663
18. Emery R.E., Stevens J.S., Nash R.W., et al. Sentinel node staging of primary melanoma by the "10% rule": pathology and clinical outcomes. Am J of Surg 193 5 (2007) 618-622
19. Wrightson W.R., Wong S.L., Edwards M.J., et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 10 (2003) 676-680
20. Cochran A.J., Essner R., Rose D.M., et al. Principles of sentinel lymph node identification: background and clinical implications. Langenbecks Arch Surg 385 (2000) 252-260
21. Gipponi M., Solari N., Lionetto R., et al. The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group. Eur J Surg Oncol 31 (2005) 1191-1197
22. Morton D.L., Thompson J.F., Essner R., et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma. A multicenter trial. Ann Surg 230 (1990) 453-463
23. Gershenwald J.E., Thompson W., Mansfield P.F., et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 162 stage I and II melanoma patients. J Clin Oncol 17 (1999) 976-983
24. Gershenwald J.E., Colome M.I., Lee J.E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16 (1998) 2253-2260
25. Gadd M.A., Cosimi A.B., Yu J., et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 134 (1999) 381-387